Andreas Kjær

Andreas Kjær

Professor


  1. 2016
  2. Published

    In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT

    Petersen, A. L., Henriksen, J. R., Binderup, Tina, Elema, D. R., Rasmussen, P. H., Hag, Anne Mette Fisker, Kjær, Andreas & Andresen, T. L., May 2016, In: European Journal of Nuclear Medicine and Molecular Imaging. 43, 5, p. 941-52 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study

    Rasmussen, L. J. H., Knudsen, A., Katzenstein, T. L., Gerstoft, Jan, Obel, Niels, Jørgensen, Niklas Rye, Kronborg, Gitte, Benfield, Thomas, Kjær, Andreas, Eugen-Olsen, J. & Lebech, Anne-Mette, May 2016, In: HIV Medicine. 17, 5, p. 350-7 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2

    Li, F., Jørgensen, Jesper Tranekjær, Forman, Julie Lyng, Hansen, A. E. & Kjær, Andreas, Mar 2016, In: Journal of Nuclear Medicine. 57, 3, p. 437-443 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma

    Nedergaard, M. K., Michaelsen, Signe Regner, Perryman, L., Erler, Janine, Poulsen, H. S., Stockhausen, M., Lassen, Ulrik Niels & Kjær, Andreas, Mar 2016, In: Nuclear Medicine and Biology. 43, 3, p. 198-205 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection

    Haissman, J. M., Knudsen, A., Hoel, H., Kjær, Andreas, Kristoffersen, U. S., Berge, R. K., Katzenstein, T. L., Svardal, A., Ueland, T., Aukrust, P., Lebech, Anne-Mette, Nielsen, S. D. & Trøseid, M., 1 Feb 2016, In: Journal of Acquired Immune Deficiency Syndromes. 71, 2, p. 130-136 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients

    Christensen, Anders, Stræde, Karina, Charabi, Birgitte Wittenborg, Mortensen, Jann, Kiss, K., Kjær, Andreas & von Buchwald, Christian, Feb 2016, In: Annals of Surgical Oncology. 23, 2, p. 565-72 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma

    Persson, M., Nedergaard, M. K., Brandt-Larsen, M., Skovgaard, D., Jørgensen, Jesper Tranekjær, Michaelsen, Signe Regner, Madsen, J., Lassen, Ulrik Niels, Poulsen, H. S. & Kjær, Andreas, Feb 2016, In: Journal of Nuclear Medicine. 57, 2, p. 272-278 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts

    Fliedner, F. P., Hansen, A. E., Jørgensen, Jesper Tranekjær & Kjær, Andreas, 14 Jan 2016, In: BMC Medical Imaging. 16, 8 p., 5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Quantitative PET Imaging of Tissue Factor Expression Using 18F-labled Active Site Inhibited Factor VII

    Nielsen, Carsten Haagen, Erlandsson, M., Jeppesen, T. E., Wessel, Mette Munk, Kristensen, L. K., Madsen, J., Petersen, L. C. & Kjær, Andreas, 1 Jan 2016, In: The Journal of Nuclear Medicine. 57, 1, p. 89-95 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180

    Engelholm, Lars Henning, Carlsen Melander, E. M., Hald, A., Persson, M., Madsen, D. H., Jürgensen, Henrik Jessen, Johansson, K., Nielsen, C., Nørregaard, Kirstine Sandal, Ingvarsen, S. Z., Kjær, Andreas, Trovik, C. S., Lærum, O. D., Bugge, T. H., Eide, J. & Behrendt, Niels, Jan 2016, In: Journal of Pathology. 238, 1, p. 120-33 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13402